With con­sumer health be­hind it, GSK taps As­traZeneca vet Julie Brown as CFO for R&D-fo­cused fu­ture

Four years ago, Em­ma Walm­s­ley re­cruit­ed Iain Mack­ay from the bank­ing world to be­come GSK’s CFO, spot­light­ing his “track record of dri­ving cost, cash and cap­i­tal al­lo­ca­tion dis­ci­pline to de­liv­er strat­e­gy.” Now that he’s helped over­see the spin­off of GSK’s con­sumer health unit, Walm­s­ley is turn­ing to an in­dus­try vet­er­an for his suc­ces­sor.

Julie Brown, a vet­er­an of As­traZeneca who re­cent­ly switched lanes to be­come Burber­ry’s chief op­er­at­ing and fi­nan­cial of­fi­cer, will join GSK as CFO in April as Mack­ay re­tires.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER